| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2141885 | Lung Cancer | 2011 | 6 Pages |
Abstract
HER2 mutations are present in a subset of patients with lung cancer having distinct clinical features. HER2 mutations were not associated with the prognosis of patients with lung cancers. Patients with HER2 mutations might benefit from anti-HER2 therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kenji Tomizawa, Kenichi Suda, Ryoichi Onozato, Takayuki Kosaka, Hideki Endoh, Yoshitaka Sekido, Hisayuki Shigematsu, Hiroyuki Kuwano, Yasushi Yatabe, Tetsuya Mitsudomi,